Since the RNA-sequencing data suggested that EphB4 knockdown on cancer cells also affected angiogenic markers (Fig. 5a), we determined the effects of EphB4 cancer cell knockdown on the vascular TME by CD31 immunohistochemical (IHC) staining. This evidence concerns the gene EPHB4 and cancer.